These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. Quinn N; Marsden CD J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286 [TBL] [Abstract][Full Text] [Related]
4. Acute challenge with apomorphine in Huntington's disease: a double-blind study. Albanese A; Cassetta E; Carretta D; Bentivoglio AR; Tonali P Clin Neuropharmacol; 1995 Oct; 18(5):427-34. PubMed ID: 8665556 [TBL] [Abstract][Full Text] [Related]
5. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial. Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335 [TBL] [Abstract][Full Text] [Related]
6. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea]. Donatelli L Clin Ter; 1977 Jun; 81(5):395-416. PubMed ID: 18317 [No Abstract] [Full Text] [Related]
7. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea. Lal S; De la Vega C; Garelis E; Sourkes TL Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059 [No Abstract] [Full Text] [Related]
8. Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism. Corsini GU; Zompo MD; Cianchetti C; Mangoni A Psychopharmacologia; 1976 May; 47(2):169-73. PubMed ID: 1273213 [TBL] [Abstract][Full Text] [Related]
9. Apomorphine in Huntington's chorea: clinical observations and theoretical considerations. Tolosa ES; Sparber SB Life Sci; 1974 Oct; 15(7):1371-80. PubMed ID: 4283614 [No Abstract] [Full Text] [Related]
10. Schizophrenic symptoms improve with apomorphine. Tamminga CA; Schaffer MH; Smith RC; Davis JM Science; 1978 May; 200(4341):567-8. PubMed ID: 347574 [TBL] [Abstract][Full Text] [Related]
11. A double blind trial of lithium carbonate and haloperidol in Huntington's chorea. Leonard DP; Kidson MA; Brown JG; Shannon PJ; Taryan S Aust N Z J Psychiatry; 1975 Jun; 9(2):115-8. PubMed ID: 125578 [TBL] [Abstract][Full Text] [Related]
12. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists]. Pollak P; Gaio JM; Hommel M; Pellat J; Perret J; Chateau R Rev Neurol (Paris); 1982; 138(5):409-13. PubMed ID: 7146725 [TBL] [Abstract][Full Text] [Related]
15. The acute effect of haloperidol and apomorphine on the severity of stuttering. Burns D; Brady JP; Kuruvilla K Biol Psychiatry; 1978 Apr; 13(2):255-64. PubMed ID: 667231 [TBL] [Abstract][Full Text] [Related]
16. Effects of DA agonist in Huntington disease hyperkinesia. Caraceni TA; Girotti F; Giovannini P; Pederzoli M; Parati EA Ital J Neurol Sci; 1980 Jun; 1(3):155-61. PubMed ID: 6210644 [TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine agonists and antagonists in Tourette's disease. Feinberg M; Carroll BJ Arch Gen Psychiatry; 1979 Aug; 36(9):979-85. PubMed ID: 380492 [TBL] [Abstract][Full Text] [Related]
19. Studies on the anti-dyskinesia effect of apomorphine in man. Tolosa ES Neurol Neurocir Psiquiatr; 1976; 17(4):223-9. PubMed ID: 138800 [TBL] [Abstract][Full Text] [Related]
20. Ergot alkaloids and cyclic nucleotides in the CNS. Trabucchi M; Hofmann M; Montefusco O; Spano PF Pharmacology; 1978; 16 Suppl 1():150-55. PubMed ID: 205889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]